These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37905925)

  • 1. Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles as Highly Potent and In Vivo Efficacious Tryptophan Hydroxylase Inhibitors.
    Specker E; Wesolowski R; Schütz A; Matthes S; Mallow K; Wasinska-Kalwa M; Winkler L; Oder A; Alenina N; Pleimes D; von Kries JP; Heinemann U; Bader M; Nazaré M
    J Med Chem; 2023 Nov; 66(21):14866-14896. PubMed ID: 37905925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.
    Specker E; Matthes S; Wesolowski R; Schütz A; Grohmann M; Alenina N; Pleimes D; Mallow K; Neuenschwander M; Gogolin A; Weise M; Pfeifer J; Ziebart N; Heinemann U; von Kries JP; Nazaré M; Bader M
    J Med Chem; 2022 Aug; 65(16):11126-11149. PubMed ID: 35921615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-Specific Substrate Inhibition Mechanism of Human Tryptophan Hydroxylase.
    Tidemand KD; Peters GH; Harris P; Stensgaard E; Christensen HEM
    Biochemistry; 2017 Nov; 56(46):6155-6164. PubMed ID: 29035515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
    Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
    J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis.
    Martínez A; Knappskog PM; Haavik J
    Curr Med Chem; 2001 Jul; 8(9):1077-91. PubMed ID: 11472242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.
    Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Evolution of Tryptophan Hydroxylases in Vertebrates: A Comparative Genomic Survey.
    Xu J; Li Y; Lv Y; Bian C; You X; Endoh D; Teraoka H; Shi Q
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30857219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan Hydroxylase-2-Mediated Serotonin Biosynthesis Suppresses Cell Reprogramming into Pluripotent State.
    Sinenko SA; Kuzmin AA; Skvortsova EV; Ponomartsev SV; Efimova EV; Bader M; Alenina N; Tomilin AN
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental role of tryptophan hydroxylase in the nervous system.
    Nakamura K; Hasegawa H
    Mol Neurobiol; 2007 Feb; 35(1):45-54. PubMed ID: 17519505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of serotonin synthesis: A novel therapeutic paradigm.
    Bader M
    Pharmacol Ther; 2020 Jan; 205():107423. PubMed ID: 31629717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.
    Nakamura K; Sugawara Y; Sawabe K; Ohashi A; Tsurui H; Xiu Y; Ohtsuji M; Lin QS; Nishimura H; Hasegawa H; Hirose S
    J Neurosci; 2006 Jan; 26(2):530-4. PubMed ID: 16407550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Serotonin Synthesis as a New Drug Target.
    Matthes S; Bader M
    Trends Pharmacol Sci; 2018 Jun; 39(6):560-572. PubMed ID: 29628275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p-ethynylphenylalanine: a potent inhibitor of tryptophan hydroxylase.
    Stokes AH; Xu Y; Daunais JA; Tamir H; Gershon MD; Butkerait P; Kayser B; Altman J; Beck W; Vrana KE
    J Neurochem; 2000 May; 74(5):2067-73. PubMed ID: 10800950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.
    Shi H; Cui Y; Qin Y
    Chem Biol Drug Des; 2018 Jan; 91(1):202-212. PubMed ID: 28719094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.
    Savelieva KV; Zhao S; Pogorelov VM; Rajan I; Yang Q; Cullinan E; Lanthorn TH
    PLoS One; 2008; 3(10):e3301. PubMed ID: 18923670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations in the Level of mRNA of TPH1, TPH2 Genes, Tryptophan Hydroxylase Activity and Serotonin Metabolism in Mouse Brain Five Days after Lipopolysaccharide Administration].
    Sherbakov DV; Arefieva AB; Komleva PD; Iz'urov AE; Khotskin NV; Bazovkina DV; Kulikov AV
    Mol Biol (Mosk); 2023; 57(2):299-306. PubMed ID: 37000657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus causes changes in the activity and expression of brain tryptophan-5-hydroxylases and in the number of serotonergic neurons, which do not return to normal with insulin treatment.
    Manjarrez-Gutiérrez G; Mondragón-Herrera JA; Hernández-Rodríguez J
    Gac Med Mex; 2022; 158(4):182-189. PubMed ID: 36256550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis.
    Betari N; Sahlholm K; Ishizuka Y; Teigen K; Haavik J
    Future Med Chem; 2020 Aug; 12(16):1461-1474. PubMed ID: 32752885
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of tryptophan hydroxylase with bound amino acid substrate.
    Windahl MS; Petersen CR; Christensen HE; Harris P
    Biochemistry; 2008 Nov; 47(46):12087-94. PubMed ID: 18937498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease.
    Waløen K; Kleppe R; Martinez A; Haavik J
    Expert Opin Ther Targets; 2017 Feb; 21(2):167-180. PubMed ID: 27973928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.